Zealand Pharma aims to raise $900M; Boehringer discontinues three Phase 2 trials

Plus, news about Lundbeck, Otsuka, Jubilant Pharma, Frontier Medicines, AstraZeneca and BenevolentAI:

Zealand Pharma targets $900M raise: The Danish biotech aims to secure the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Opinion | I Love Being the ‘ER Dad’

Edwin Leap is a board-certified emergency physician who has been practicing for 30 years since finishing residency. He currently works as an emergency physician for

November 25, 2023

NorthShore – Edward-Elmhurst Health Signs Largest VBC Deal in 5 Years

What You Should Know: – Edward-Elmhurst Health (NS-EEH) has announced a significant, long-term partnership with Lumeris, a pioneer in value-based care (VBC). This partnership is

November 2, 2023

Impact of diet on health outcomes among United Kingdom Biobank participants

The association between diet and health outcomes among United Kingdom Biobank (UKBB) participants.

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.